Yahoo is ready to buy Chrome browser if Google is forced to sell
Internet company Yahoo Inc. — backed by owner Apollo Global Management Inc. — would bid for the Chrome web browser if a federal court orders Google to divest it as a remedy for maintaining an illegal monopoly, a senior executive said.
Brian Provost, the general manager for Yahoo Search, testified Thursday during Google's trial in Washington that his company estimates the browser would have a sale price in the tens of billions of dollars.
Chrome is 'arguably the most important strategic player on the web,' Provost said. 'We would be able to pursue it with Apollo.'
Provost testified as part of a three-week hearing in the Justice Department's case against Alphabet Inc.'s Google to determine how to remedy the company's monopoly in internet search. Judge Amit Mehta ruled last year Google illegally monopolized the market and is contemplating a package of changes proposed by antitrust enforcers.
The Justice Department and a group of U.S. states have argued that Google should be forced to sell off its popular Chrome browser.
Yahoo was the leading search engine in the early 2000s before losing that position to Google. The company has changed hands several times; Apollo purchased it in 2021 from Verizon Communications Inc.
Since the Apollo takeover, Yahoo has been seeking to 'revitalize' its search engine, and started building its own browser that remains in development, Provost said. The company has also considered buying a browser and became interested in purchasing Chrome as soon as the Justice Department's proposal became public, he said.
Yahoo would likely have competition. OpenAI also would be interested in buying Chrome browser, the head of ChatGPT said during the trial Tuesday.
'Yes, we would, as would many other parties,' Nick Turley, OpenAI's ChatGPT chief, said in response to a question about whether the company would seek to buy Google's browser.
___
© 2025 Bloomberg L.P.
Distributed by Tribune Content Agency, LLC.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting
TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ('MediPharm' or the 'Company'), a pharmaceutical company specialized in precision-based cannabinoids, today announced that the Superior Court of Justice – Ontario (Commercial List) (the 'Court') has fully dismissed the application (CV-25-00743454-00CL) (the 'Application') issued by Apollo Technology Capital Corporation ('Apollo') and Nobul Technologies Inc. (together with Apollo, the 'Applicants') against the Company on May 16, 2025 (the 'Notice'). The Applicants sought an order from the Court, amongst other things, appointing a third-party independent chair to preside over the Annual and Special Meeting of Shareholders of the Company (the 'Meeting') on June 16, 2025. The Applicants argued that MediPharm has a 'design or plan to invalidate proxies' and that the Company had acted improperly warranting the appointment of a third-party independent chair. The Court dismissed the Application in full. In doing so, the Court found that a third-party independent chair was not required in the circumstances as there was no evidence or indication that MediPharm's proposed meeting chair will act unfairly at the Meeting. Regarding the conduct of Apollo's principal, Mr. Regan McGee, the Court found: 'The evidence shows that Mr. McGee has threatened to release a draft press release which, among other things, compared Mr. Pidduck to known serial killers. Press Releases have also been issued by Mr. McGee or the Applicants which accuse MediPharm and the Board of securities fraud, breach of fiduciary duty and running a corrupt election process to entrench themselves. Mr. McGee has threatened to sue the Board by way of a derivative action for breach of fiduciary duty and associated damages because of the rejection of the $3.4 million offer and has commenced a lawsuit against MediPharm, two of its senior officers and directors, as well as the Company's external litigation firm (Tyr LLP) and counsel (James Bunting) which claimed $50 million in damages. Mr. McGee, repeated the allegations set out in the lawsuit in the Dissident Circular and then abandoned and withdrew the claim against Tyr LLP and Mr. Bunting, and agreed to terms of settlement that included a declaration by Mr. McGee that Tyr LLP and Mr. Bunting are not in a conflict of interest in acting for MediPharm, that they had not misused confidential information, that Mr. McGee would not disparage Mr. Bunting or Tyr LLP and provided a full release to Tyr LLP and Mr. Bunting.' The Company remains committed to a fair shareholder meeting process, in compliance with its constating documents and all applicable laws. We encourage shareholders to please vote using ONLY the GREEN proxy or GREEN voting instruction card and to support each of the director nominees recommended by MediPharm's Board of Directors (the 'Board') and the other matters being considered at the Meeting. To ensure your proxy is counted at the Meeting, please submit it well in advance of the June 13 proxy cut-off. Vote for the Highly Qualified MediPharm Nominees MediPharm urges shareholders to vote only using the GREEN proxy or GREEN voting instruction form in support of all of the Company's nominees and resolutions. To ensure your vote is counted, shareholders are encouraged to proactively contact their broker to obtain their 16-digit control number associated with the GREEN management proxy. Once received, you can cast your vote by visiting You may receive materials or outreach from the dissident — please disregard any such communications and vote only using the GREEN proxy in support of the Company's nominees. About MediPharm Labs Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities for delivery of pure, trusted and precision-dosed cannabis products for its customers. MediPharm Labs develops, formulates, processes, packages and distributes cannabis and advanced cannabinoid-based products to domestic and international medical markets. In 2021, MediPharm Labs received a Pharmaceutical Drug Establishment License from Health Canada, becoming the only company in North America to hold a commercial-scale domestic Good Manufacturing Practices License for the extraction of multiple natural cannabinoids. This GMP license was the first step in the Company's current foreign drug manufacturing site registration with the US FDA. In 2023, MediPharm acquired VIVO Cannabis Inc., which expanded MediPharm's reach to medical patients in Canada via Canna Farms medical ecommerce platform, and in Australia and Germany through Beacon Medical Australia PTY Ltd. and Beacon Medical Germany GMBH. This acquisition also included Harvest Medical Clinics in Canada which provides medical cannabis patients with Physician consultations for medical cannabis education and prescriptions. The Company carries out its operations in compliance with all applicable laws in the countries in which it operates. Shareholder Voting Assistance: If you have any questions or require any assistance in executing your GREEN proxy or voting instruction form, please call Sodali & Co at: North American Toll-Free Number: 1.888.777.2059Outside North America, Banks, Brokers and Collect Calls: 1.289.695.3075Email: assistance@ American Toll-Free Facsimile: 1.877.218.5372 For up-to-date information and assistance in voting please visit: Investor Contact: MediPharm Labs Investor RelationsTelephone: +1 416.913.7425Email: investors@ Media Contact: John VincicOakstrom Advisors+1 (647) 402-6375john@ Cautionary Note Regarding Forward-Looking Information: This news release contains 'forward-looking information' and 'forward-looking statements' (collectively, 'forward-looking statements') within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as 'expects', or 'does not expect', 'is expected', 'anticipates' or 'does not anticipate', 'plans', 'budget', 'scheduled', 'forecasts', 'estimates', 'believes' or 'intends' or variations of such words and phrases or stating that certain actions, events or results 'may' or 'could', 'would', 'might' or 'will' be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate to, among other things: timing of the Annual and Special Meeting, any impacts to MediPharm shareholders of the actions relating to the Applicants or Mr. McGee, and any outcomes resulting from the circumstances and information cited herein. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; the inability of MediPharm Labs to obtain adequate financing; the delay or failure to receive regulatory approvals; and other factors discussed in MediPharm Labs' continuous disclosure filings, available on the SEDAR+ website at There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, MediPharm Labs assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they in to access your portfolio
CNET
16 minutes ago
- CNET
Google Releases Android 16 Months Earlier Than Expected. Here's How You Can Download It
A day after Apple announced iOS 26 at WWDC 25, Google has launched one of its most ambitious releases yet with the official launch of Android 16. Rolling out first to most supported Pixel phones, Android 16 lands months earlier than recent major versions, with a focus on productivity features and enhancements. These include Live Updates for tracking deliveries and rideshare cars, streamlined notifications, the ability to use desktop-style windows when your phone's connected to a monitor, new device security features, native controls for hearing aids and more. Shipping the OS in June, instead of the traditional August to September window, lets Google push fresh features into users' hands sooner, and gives phone makers extra runway to preload Android 16 on new phones set to debut in the fall. For Pixel owners, the update begins rolling out at 11 a.m. PT, with support for third-party phones coming later this year. Developers, meanwhile, get a new QPR beta that enables the external-monitor preview so they can start optimizing apps for bigger workspaces. Here's what you need to know. Android 16 arrives first on the Pixel Google is pushing a stable build of Android 16 to most supported Pixel phones today. The update layers a fresh Material 3 Expressive coat of paint on top of the OS and adds several new features, too. Android 16 will run on the Pixel 6 and later. Andrew Hoyle/CNET Live update and streamlined notifications If you're waiting for your sushi to arrive or watching your rideshare slowly inch across town, Android 16 now offers live updates that are pinned to your lock screen, so you don't have to keep opening an app to stay in the know. Also, notifications from the same app are now automatically grouped, reducing clutter on your lock screen from notification-heavy apps like Gmail and Ring. You won't receive individual notifications for a single app anymore. Google One-tap Advanced Protection for everyone A single toggle now bundles Google's toughest defenses, blocking dodgy websites, scam calls and even USB attacks while the phone is locked. Originally built for high-risk users like journalists and politicians, Advanced Protection is free and available for everyone on Android 16. Clearer calls for those with hearing aids If you use Bluetooth LE hearing aids, Android 16 lets you flip a switch that routes your voice through the phone's superior microphones instead of the tiny mics in your hearing aids, perfect for when you're in a bustling coffee shop or windy beach. There's also a new on-device panel for adjusting hearing-aid volume and presets in one place. Android 16 brings improvements for people who use hearing aids. Google Better productivity for tablet owners Tablet owners running Android 16 will get a desktop windowing mode later this year, built in partnership with Samsung. It lets you float, snap or resize multiple app windows on your device, like you would on a desktop, and Android 16 lays the groundwork for that. Android 16's desktop windowing will be released later this year. Google Android 16 supported devices Android 16 is initially rolling out to some Google Pixel devices: How to download Android 16 If you want to download and install Android 16 today, grab your Pixel and go to Settings > System > Software update > Check for update, and the roughly 2GB download should appear. If you don't see the update yet, just wait -- it's slowly rolling out to users today. Before you download, make sure your phone is on Wi-Fi, plug your phone in if the battery's low, and back up anything critical before you install. Once the file finishes, a quick reboot should complete the upgrade. Owners of Samsung, OnePlus and other Android devices will need to wait for their manufacturers' rollout notices later this year, but the process will be the same: Head to the software-update screen and follow the on-screen prompts. If you're on the Android 16 beta, you can turn your Pixel into a plug-and-play desktop Google's latest Android 16 beta (QPR1 Beta 2) lets Pixel 8 and Pixel 9 owners turn their phones into mini desktops. All you need to do is plug your phone to any external monitor with a USB-C cable, and a full task-bar-and-window interface will appear. You can juggle multiple apps side-by-side, pin favorites and even use keyboard shortcuts. You need to enable desktop experience features in the developer settings. Google If you want to try out the Android 16 Beta, you can enroll your Pixel 8 or 9 at then go to Settings > System > Software update to download the Android 16 QPR1 Beta 2 over the air. Non-Android 16 new features also released today Alongside Android 16, Google is releasing half a dozen features across the wider Android ecosystem today: Custom group chats . You can pick an icon and name, see who's on RCS and set a timed mute. . You can pick an icon and name, see who's on RCS and set a timed mute. Smarter Google Photos editor. Use one-tap AI fixes, text-prompt "Reimagine" edits and auto-crop. Use one-tap AI fixes, text-prompt "Reimagine" edits and auto-crop. Room-specific Google Home shortcuts. You can pin a camera to your TV, lights to your phone, thermostat to your watch. You can pin a camera to your TV, lights to your phone, thermostat to your watch. Extend Safety Check timers. Add extra minutes from the phone or Wear OS without restarting the countdown. Add extra minutes from the phone or Wear OS without restarting the countdown. Fresh Emoji Kitchen mash-ups. For more expressive stickers, you can create new combos like pointing pigs and thankful carrots. For more expressive stickers, you can create new combos like pointing pigs and thankful carrots. Faster transit taps on Wear OS. Swipe your watch and pay, even with Google Wallet closed. These are all the new features being released today across the entire Android ecosystem, not just Android 16. Google All six arrive via Play Services and app updates, no upgrade required.
Yahoo
26 minutes ago
- Yahoo
Papa John's Stock Jumps on News of Possible Go-Private Deal
Shares of Papa John's jumped Wednesday on the news that the pizza chain might be taken private. Papa John's International (PZZA) stock finished the session up 7.5%, after rising as much as 15% earlier in the day to its highest level since November. A Semafor report said that asset manager Apollo and Irth Capital Management have bid to take the company private in a deal valuing it at about $2 billion. Papa John's market capitalization is around $1.6 billion, according to Visible Alpha. Irth Capital, which is associated with Qatar's royal family, as well as Apollo and Papa John's, did not respond to Investopedia's requests for comment in time for publication. Papa John's in early May reported first-quarter North American comparable-store sales that were down year-over-year. Its shares' value has risen more than a quarter this year, climbing off April lows. Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
